$VTGN 👀 Catalyst Watch Into Month-End 🔹 Vistagen said topline results from PALISADE-4 Phase 3 are expected this month 📅 🔹 Fasedienol is targeting acute trea

$VTGN 👀 Catalyst Watch Into Month-End 🔹 Vistagen said topline results from PALISADE-4 Phase 3 are expected this month 📅 🔹 Fasedienol is targeting acute treatment of social anxiety disorder — a massive unmet need 🧠 🔹 Company also completed its Phase 2 repeat-dose study, with results expected in…